Specifically, in bone, CCL2 is known to be involved in a destructive cascade, being released after PTHrP stimulation of osteoblasts, which in turn secretes CCL2 in the bone marrow activating osteoclastogenesis and tumor growth [28]. The gene discussed is PTHLH; the disease is neoplasm.